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Karl F. Welke, MD,a Sean M. O’Brien, PhD,b Eric D. Peterson, MD, MPH,b Ross M. Ungerleider, MD, MBA,c
Marshall L. Jacobs, MD,d and Jeffery P. Jacobs, MDe
Objective:We sought to determine the association between pediatric cardiac surgical volume and mortality using
sophisticated case-mix adjustment and a national clinical database.
Methods: Patients 18 years of age or less who had a cardiac operation between 2002 and 2006 were identified in
the Society of Thoracic Surgeons Congenital Heart Surgery Database (32,413 patients from 48 programs).
Programs were grouped by yearly pediatric cardiac surgical volume (small,<150; medium, 150–249; large,
250–349; and very large,350 cases per year). Logistic regression was used to adjust mortality rates for volume,
surgical case mix (Aristotle Basic Complexity and Risk Adjustment for Congenital Heart Surgery, Version 1
categories), patient risk factors, and year of operation.
Results: With adjustment for patient-level risk factors and surgical case mix, there was an inverse relationship
between overall surgical volume as a continuous variable and mortality (P¼ .002). When the data were displayed
graphically, there appeared to be an inflection point between 200 and 300 cases per year. When volume was an-
alyzed as a categorical variable, the relationship was most apparent for difficult operations (Aristotle technical
difficulty component score,>3.0), for which mortality decreased from 14.8% (60/406) at small programs to
8.4% (157/1858) at very large programs (P¼ .02). The same was true for the subgroup of patients who underwent
Norwood procedures (36.5% [23/63] vs 16.9% [81/479], P<.0001). After risk adjustment, all groups performed
similarly for low-difficulty operations. Conversely, for difficult procedures, small programs performed signifi-
cantly worse. For Norwood procedures, very large programs outperformed all other groups.
Conclusion: There was an inverse association between pediatric cardiac surgical volume and mortality that
became increasingly important as case complexity increased. Although volume was not associated with mortality
for low-complexity cases, lower-volume programs underperformed larger programs as case complexity increased.
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The drive to quantify and publicly report hospital quality has
intensified the search for comparable quality measures. Be-
cause of its simplicity and ready availability, surgical volume
is one of the most often cited metrics. The relationship be-
tween hospital surgical volume and in-hospital mortality for
coronary artery bypass grafting surgery has been one of the
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has depended on the database used. The inverse association
between hospital volume and mortality is more apparent in
administrative data than in clinical data.1,2 This is in part
due to the more sophisticated risk adjustment possible with
clinical data and differences in the cohorts of hospitals.3
Although less studied, the relationship between hospitals’
pediatric cardiac surgical volumes and mortality rates has
been the subject of several previous investigations.4-9 These
studies have used either administrative data or single-state
clinical data. The largest and most recent of these studies
demonstrated an inverse and nonlinear association between
volume and mortality after adjustment for patient age and
surgical case mix.9 Although this study benefited from a na-
tional database, the reliance on administrative data limited
the ability to adjust for patient-level risk factors. Surgical
case-mix designation was also limited by administrative
coding.
The purpose of our study was to determine the relationship
between program surgical volume and mortality after pediatric
cardiac surgery. For the investigation, we used clinical data
from the Society of Thoracic Surgeons (STS) Congenital Heart
Surgery Database. We first examined the raw association
between overall surgical volume and mortality. We then inves-
tigated how this association is affected by adjustment for both
patient-level risk factors and surgical case mix.ardiovascular Surgery c Volume 137, Number 5 1133
Congenital Heart Disease Welke et al
C
H
DAbbreviations and Acronyms
ABC ¼ Aristotle Basic Complexity
O/E ¼ observed mortality/expected mortality
OR ¼ odds ratio
RACHS-1 ¼ Risk Adjustment for Congenital Heart
Surgery, Version 1
STS ¼ Society of Thoracic Surgeons
MATERIALS AND METHODS
Database
This study was designed as a retrospective cohort analysis. We obtained
data from the STS Congenital Heart Surgery Database.10 The STS maintains
the provider-led voluntary cardiac surgical clinical database as a means of
supporting national quality-improvement efforts. The database grew from
6790 operations from 20 participants during calendar year 2002 to 19,853
operations from 56 participants during calendar year 2006. Database partic-
ipants are either hospitals or surgical groups that are affiliated with hospitals
at which cardiac surgery is performed. Each record corresponds to a primary
cardiac surgical procedure. Data elements include basic patient demo-
graphic information, comorbidities and preoperative risk factors, diagnoses,
type of operation, and outcomes, including in-hospital mortality, 30-day
mortality, major morbidity, and postoperative length of stay.
Study Population
The study population consisted of patients age 18 years or less who
underwent a cardiovascular operation at an STS-participating program
between January 1, 2002, and December 31, 2006. Programs were excluded
if they had more than 10% missing data on key study variables, including
preoperative risk factors, noncardiac abnormalities, discharge mortality, and
length of stay. Ten programs were deleted because of data quality issues,
leaving 48 programs in the study cohort. Seven of the 48 programs per-
formed operations at 2 hospitals. In each case the vast majority of operations
were performed at one of the hospitals. Patients were initially included if
they underwent one of the cardiovascular procedures for which the Aristotle
Basic Complexity (ABC) Score and/or the Risk Adjustment for Congenital
Heart Surgery, Version 1 (RACHS-1) complexity level is defined.11,12 In
addition to cardiovascular procedures, the ABC score is also defined for
13 noncardiovascular procedures that were excluded from the analysis.
Patients undergoing one of these 13 noncardiovascular procedures were
only included if the noncardiovascular procedure was performed concomi-
tantly with a cardiovascular procedure and was not the primary procedure of
the operation. In addition, patients weighing less than or equal to 2500 g
undergoing patent ductus arteriosus ligation as their primary procedure
were excluded from the analysis. In cases in which patients had multiple
operations during the same hospital admission, only the first operation
was analyzed. Finally, patients were excluded if they were missing data
on 2 key risk-adjustment variables: age and weight.
Definition of Surgical Volumes
Average annual program volumes were based on operations submitted to
the STS database between January 1, 2002, and December 31, 2006. Case
volumes were defined by counting the number of admissions for which the
index operation (first operation of the hospitalization) was cardiovascular.
The average annual program volume was calculated by dividing the number
of admissions during the study period by the number of months that the
program participated in the database during the study period and then mul-
tiplying by 12. For tabular presentation, volumes were categorized into 4
groups: less than 150, 150 to 249, 250 to 349, and 350 or more cases per
year. These categories were chosen to ensure an adequate sample size (num-1134 The Journal of Thoracic and Cardiovascular Sber of events) in each category when analyzed in the overall population, as
well as subgroups. The association between volume and mortality was also
explored without categorizing volume, as described below.
We repeated the calculation of surgical volumes by counting the total
number of cardiovascular operations (instead of the number of admissions).
When these operation-based volumes were compared with the original
admission-based volumes, the Pearson correlation was 0.99. Hence there
is little risk that a program’s volume status was misclassified based on the
decision to define volume in terms of admissions or operations.
End Point
Our primary end point was in-hospital mortality, which was defined as
death during the same hospitalization as the operation, regardless of timing.
Analysis of Mortality
Unadjusted mortality rates were compared across volume categories by
using logistic regression with generalized estimating equations to account
for correlation of outcomes within hospitals. A linear trend test was con-
ducted by assigning integer scores to the volume categories and testing
whether the coefficient for these integer scores was zero. Next, a generalized
estimating equation logistic regression model was used to assess the associ-
ation between volume and mortality while adjusting for patient-level risk
factors and surgical case mix.
Patient-level risk factors. The following variables were included
in the adjusted mortality model: age (modeled as a piecewise linear variable
with knots at 30 days and 1 year); age-for-weight-and-sex z score; interac-
tion between age and age-for-weight-and-sex z score; preoperative stay for
more than 2 days; number of prior operations (0, 1, and2); renal failure or
dialysis; acidosis, circulatory support, or shock; preoperative ventilatory
support or tracheostomy; asplenia, polysplenia, or a22q11 deletion;
DiGeorge syndrome; Down syndrome; procedure or procedure group;
and operation date (modeled as a linear trend).
Modeling of volume. Volume was initially modeled as a categorical
variable, with categories corresponding to less than 150, 150 to 249, 250 to
349, and 350 or more cases per year. Because categorization can reduce
statistical power, the analysis was also performed by entering volume in
the model as a single continuous linear variable. This approach was used
for testing the overall null hypothesis of no association between volume
and mortality. Finally, to explore possible nonlinear volume effects, volume
was analyzed by using restricted cubic splines. Knots for the spline function
were placed at 150, 250, and 350 cases per year. Because the shape of
a spline function might depend on the choice of arbitrary knot locations,
the model was subsequently repeated by using 2 alternative specifications:
knots at 100, 300, and 500 cases and knots at 200, 300, and 450 cases.
Adjustment for type of procedure. Because of the large number
of procedures with small sample sizes, it was not feasible to adjust for proce-
dure identity by including a separate term for each individual procedure. In-
stead, a coarser covariate adjustment was performed by grouping
procedures of similar complexity. Any procedure with at least 20 deaths re-
corded in the database was considered to be its own stratum. All remaining
procedures were stratified by ABC level and RACHS-1 category. The possi-
ble values of the ABC level were 1, 2, 3, 4, and ‘‘unassigned.’’ The possible
values of the RACHS-1 level were 1, 2, 3, 4, 6, and ‘‘unassigned.’’ ‘‘Unas-
signed’’ indicates that the procedure type was not included by the developers
of the ABC or RACHS-1 methodology. To perform the covariate adjustment,
we grouped procedures according to the 30 unique combinations of ABC and
RACHS-1 (5 levels of ABC [including ‘‘unassigned’’]36 levels of RACHS-
1 [including ‘‘unassigned’’] ¼ 30 unique combinations). Strata with zero
deaths do not provide information for studying the volume-outcome associa-
tion and were therefore excluded. The remaining 28 combinations were en-
tered into the logistic regression model as a set of category indicator variables.
Subgroup analyses. In addition to studying the overall volume–out-
come association, we also assessed the volume–outcome associationurgery c May 2009
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including an interaction between volume and difficulty in the regression
models. Procedures were classified by difficulty based on the difficulty com-
ponent of the Aristotle score. The categories were Aristotle difficulty of 3.0
or less versus 3.0 or greater. Procedures that were not classified by using the
Aristotle system were excluded from this analysis. We also performed a sep-
arate subgroup analysis to assess the volume-outcome association specifi-
cally for the Norwood operation. The Norwood operation was the only
procedure with enough events to make a standalone analysis informative.
Sensitivity analysis. To determine whether the observed volume–
outcome association was an artifact of unusually high performance at just
1 or 2 high-volume hospitals, we repeated the analysis 3 ways: (1) after
excluding the single participant with the largest average annualized number
of index operations, (2) after excluding the 2 participants with the largest
average annualized number of index operations, and (3) after excluding
the participant in the highest volume category with the lowest observed mor-
tality to expected mortality (O/E) ratio. The first program participated for 3
years, contributed 2080 cases to the regression analysis, had an average
annualized volume of 850 cases per year, and had the third lowest O/E ratio
among participants in the highest volume category. The second program
participated for 5 years, contributed 3279 cases to the regression analysis,
had an average annualized volume of 683 cases per year, and had the second
lowest O/E ratio among participants in the highest volume count. This
program contributed more cases to the regression analysis than any other
participant. (Note: the average annualized volume does not correspond to
the number of cases in the regression analysis because of differing inclu-
sion/exclusion criteria for calculating participant volumes and analyzing
outcomes.) The third program participated for 5 years, contributed 2769
cases to the analysis, had an average annualized volume of 600.6, and
had the lowest O/E ratio among participants in the analysis.
If the observed volume–outcome association disappeared after excluding
these hospitals, this might indicate that the apparent volume–outcome asso-
ciation was an artifact of unusual results at just 1 or 2 high-volume hospitals.
RESULTS
We identified 32,413 operations in the STS Congenital
Heart Surgery Database from 2002 to 2006 that met our
inclusion criteria. These operations took place at 48 pro-
grams. The average annual pediatric cardiac surgical volume
at these programs ranged from 66 to 850 cases (Figure 1).
Patient-level risk factors and surgical case mix varied by
volume category (Table 1). The case mix at larger programs
included a higher percentage of younger patients. As a result,
operations done at larger-volume programs more frequently
involved lower-weight patients. The case mix at larger-vol-
ume programs also included a greater percentage of more
complex operations. Patient demographics and preoperative
risk factors did not differ by volume category.
The overall unadjusted mortality rate for the cohort was
3.7%. When programs were grouped into 4 volume cate-
gories, the overall unadjusted mortality rate at small pro-
grams was lower than that at medium-volume programs
(4.0% vs 4.1%) and slightly higher than those at
large- and very large-volume programs (3.8% and 3.3%,
respectively; Table 2). When mortality risk was modeled as
a function of program volume categories, the c statistic was
low (0.53), indicating that volume alone was a poor predic-
tor of mortality. Adjustment for patient risk factors and sur-
gical case mix improved the discrimination of the modelThe Journal of Thoracic and Csubstantially (c statistic ¼ 0.84). After adjustment, the mor-
tality rates at medium and large programs were similar to the
mortality rates at very large programs (odds ratios [OR],
1.05 and 1.14, respectively), but compared with very large
programs, mortality at small programs was significantly
higher (OR, 1.51; P ¼ .0005; Table 3).
We then subdivided the case mix by difficulty to see
whether there was a differential effect of volume (Table 3).
For low-difficulty operations (defined as Aristotle difficulty
3.0), all 4 volume groups performed similarly (P ¼ .29,
test of trend). However, for high-difficulty operations (defined
as Aristotle difficulty>3.0), small programs had substantially
higher adjusted mortality relative to very high-volume pro-
grams (OR, 2.41; P< .0001). Mortality rates for high-diffi-
culty operations performed at medium and large programs
were similar to the mortality rates at very large programs.
We then examined the volume–mortality relationship for the
Norwood procedure. This operation was chosen because of
the high level of system knowledge and coordination needed
to achieve success. For the Norwood procedure, very high-
volume programs outperformed all other volume groups.
To further investigate the volume–mortality relationship,
we analyzed volume as a continuous variable and used logis-
tic regression to adjust for patient-level risk factors and
surgical case mix. We found an inverse relationship between
overall surgical volume as a continuous variable and mortality
(P¼ .002). We then plotted the ORs for risk-adjusted mortal-
ity by using a volume of 800 cases per year as the arbitrary
reference (OR, 1.0). For overall surgical volume, the slope
of the volume–mortality curve was steepest below an infec-
tion point, which occurred between 200 and 300 cases per
year (Figure 2). This nonlinear effect was not significant for
low-complexity cases (P ¼ .06, test of no volume–mortality
association; Figure 3) but was consistent for high-complexity
cases (P ¼ .007, test of no volume–mortality association;
Figure 3) and the Norwood operation (P< .001, test of no
volume–mortality association; Figure 4). Importantly, the
reliability of the inflection point cannot be assured because
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DTABLE 1. Baseline characteristics of the study cohort by volume category
Volume category
All <150 150–249 250–349 350
Variable N
Frequency
(%) N
Frequency
(%) N
Frequency
(%) N
Frequency
(%) N
Frequency
(%)
Participants 48 15 14 12 7
Patients 32,413 3715 6088 12,007 10,603
Demographics
Age (d) <30 6863 21.2 674 18.1 1326 21.8 2369 19.7 2494 23.5
30 and<365 11,726 36.2 1293 34.8 2268 37.3 4263 35.5 3902 36.8
365 14,824 42.7 1748 47.1 2494 41.0 5375 44.8 4207 39.7
Weight (kg) <2.5 1092 3.4 95 2.6 229 3.8 368 3.1 400 3.8
2.5 and<5.0 10,283 31.7 1102 29.7 1964 32.3 3608 30.1 3609 34.1
5.0 21,038 64.9 2518 67.8 3895 64.0 8031 66.9 6594 62.2
z Score (weight for age) <5 379 1.2 37 1.0 74 1.2 136 1.1 132 1.2
5 and<3 3122 9.6 350 9.4 620 10.2 1075 9.0 1077 10.2
3 and<1 13,262 40.9 1511 40.7 2506 41.2 4748 39.5 4497 42.4
1 and<1 13,100 40.4 1490 40.1 2424 39.8 4971 41.4 4215 39.8
>¼1 2550 7.9 327 8.8 464 7.6 1077 9.0 682 6.4
Female sex 14,608 45.1 1701 45.8 2786 45.8 5352 44.6 4769 45.0
Abnormalities
22q11 Deletion 139 0.4 25 0.7 36 0.6 61 0.5 17 0.2
DiGeorge syndrome 710 2.2 69 1.9 151 2.5 256 2.1 234 2.2
Down syndrome 2904 9.0 364 9.8 626 10.3 1028 8.6 886 8.4
Asplenia 500 1.5 52 1.4 82 1.4 187 1.6 179 1.7
Polysplenia 129 0.4 9 0.2 32 0.5 57 0.5 31 0.3
Preoperative risk factors
Preoperative length of stay 0 and<1 19,613 60.5 2286 61.6 3775 62.0 7337 61.1 6215 58.6
1 and<5 6905 21.3 750 20.2 1105 18.2 2240 18.7 2810 26.5
5 and<10 3352 10.3 342 9.2 697 11.5 1377 11.5 936 8.8
10 and<30 1858 5.7 232 6.3 393 6.5 773 6.4 460 4.3
30 675 2.1 103 2.8 116 1.9 277 2.3 179 1.7
Previous cardiothoracic
operations
0 and<1 22,477 70.7 2795 75.4 4275 70.4 7847 68.7 7560 71.4
1 and<2 4886 15.4 544 14.7 1010 16.6 1726 15.1 1606 15.2
2 4440 14.0 369 10.0 792 13.0 1849 16.2 1430 13.5
Acidosis 694 2.1 74 2.0 172 2.8 313 2.6 135 1.3
Mechanical circulatory support 72 0.2 8 0.2 8 0.1 40 0.3 16 0.2
Renal failure with or without
dialysis
323 1.0 34 0.9 63 1.0 130 1.1 96 0.9
Shock 401 1.2 74 2.0 91 1.5 163 1.4 73 0.7
Tracheostomy 105 0.3 11 0.3 34 0.6 46 0.4 14 0.1
Ventilatory support 3490 10.8 344 9.3 797 13.1 1404 11.7 945 8.9
Operative case mix
Aristotle difficulty 3.0 28,486 88.8 3329 91.4 5370 89.3 10632 89.3 8155 87.0
>3.0 3598 11.2 312 8.6 647 10.8 1270 10.7 1369 13.0
Aristotle basic complexity level 1 4932 15.4 690 19.0 883 14.7 1980 16.6 1379 13.1
2 14,123 44.0 1704 46.8 2878 47.8 5142 43.2 4399 41.8
3 8685 27.1 888 24.4 1465 24.4 3285 27.6 3047 29.0
4 4344 13.5 359 9.9 791 13.2 1495 12.6 1699 16.1
RACHS-1 category 1 4131 14.6 610 18.4 788 14.7 1437 14.1 1296 13.8
2 11,949 42.3 1503 45.4 2312 43.1 4442 43.6 3692 39.3
3 8567 30.3 910 27.5 1608 30.0 3016 29.6 3033 32.3
4 2300 8.1 215 6.5 429 8.0 823 8.1 833 8.9
5 6 0.02 0 0.00 1 0.02 1 0.01 4 0.04
6 1309 4.6 72 2.2 228 4.3 464 4.6 545 5.81136 The Journal of Thoracic and Cardiovascular Surgery c May 2009
Welke et al Congenital Heart DiseaseTABLE 2. Raw mortality rates (percentage mortality and 95% confidence interval) by volume category
Volume category
Procedure subgroup All <150 150–249 250–349 350 P value*
All procedures 3.7 (3.3–4.1) 4.0 (2.9–5.0) 4.1 (3.1–5.2) 3.8 (3.3–4.2) 3.3 (2.7–3.8) .101
Aristotle difficulty 3.0 2.6 (2.3–2.9) 2.7 (1.9–3.4) 2.9 (2.2–3.6) 2.9 (2.5–3.2) 2.2 (1.9–2.5) .086
Aristotle difficulty>3.0 9.8 (8.4–11.1) 14.8 (11.4–18.2) 11.1 (7.7–14.5) 9.3 (7.6–11.0) 8.4 (6.2–10.7) .020
Norwood procedures 21.3 (18.4–24.3) 36.5 (27.4–45.7) 24.2 (17.7–30.7) 22.7 (18.9–26.6) 16.9 (14.0-19.9) <.0001
*P value for linear trend across volume groups.C
H
Das a result of the number of programs in the cohort, the 95%
confidence intervals were not sufficiently narrow. When the
analysis was repeated by using 2 alternative specifications
for the knot locations, the shape of the curves was similar,
but the location of the inflection point increased to between
300 and 400 cases per year.
To further assess the stability of our results, we conducted
a series of sensitivity analyses. After removal of the largest
and 2 largest programs from the cohort, there was no substan-
tial difference in our findings. Similarly, removal of the low-
est-mortality program did not appreciably alter the results.
DISCUSSION
After risk adjustment for patient-level variables and surgi-
cal case mix, there was an inverse relationship between over-
TABLE 3. Association between annual case volume and mortality*
Volume category N Deaths
Adjusted odds
ratio
(95% confidence
interval) P value
All procedures
350 10,570 346 Reference .004y
250–349 11,978 450 1.05 (0.86–1.29) .63
150–249 6051 250 1.14 (0.84–1.55) .41
<150 3681 148 1.51 (1.19–1.90) .0005
Low-difficulty
procedures
350 8663 188 Reference .29y
250–349 10,252 295 1.16 (0.87–1.53) .31
150–249 5104 148 1.08 (0.76–1.52) .68
<150 3229 86 1.21 (0.87–1.69) .26
High-difficulty
procedures
350 1855 135 Reference .0008y
250–349 1636 138 0.89 (0.69–1.15) .38
150–249 894 79 1.22 (0.81–1.84) .35
<150 406 54 2.41 (1.89–3.06) <.0001
Norwood procedures
350 479 81 Reference <.0001y
250–349 418 95 1.43 (1.06–1.95) .020
150–249 194 47 1.59 (1.09–2.32) .016
<150 63 23 2.91 (1.98–4.28) <.0001
*The smaller numbers of operations in this table compared with those in Table 1 reflect
the exclusion of patients with missing risk adjustment data. Although Table 1 includes
the entire cohort, Table 3 excludes 89 patients who were in a procedure stratum with
zero deaths (as mentioned in the methods section) and 44 patients with missing mor-
tality status. yP for linear trend.The Journal of Thoracic and Caall surgical volume as a continuous variable and mortality.
When analyzed as a categorical variable, the relationship
was most apparent for difficult operations. For one of the
most complex procedures (the Norwood procedure), the
largest programs had results that were significantly better
than those of all other groups. Although volume alone was
an unreliable discriminator of mortality, mortality rates
adjusted for patient risk factors and surgical case mix sug-
gest that in aggregate higher-volume programs achieve
lower mortality rates for complex operations.
Although we did find a relationship between case volume
and mortality, this finding must be interpreted with caution.
The aggregation of programs into volume groups gave us
sufficient statistical power to analyze important relationships
but disguised individual programs. One should not conclude
that all larger programs perform better than all smaller
programs. Although on average this was true, there were
low-volume programs that had low mortality rates and those
that had volumes too low for any mortality rate difference to
be observed. Importantly, our analysis highlights the unsuit-
ability of volume alone, without adjustment for patient risk
factors and surgical case mix, as a marker of quality. In gen-
eral, a patient’s own risk characteristics and level of disease
burden account for the vast majority of his or her mortality
risk, and the effect of program volume on the mortality
risk of an individual patient is small.
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FIGURE 2. Association between overall annual volume and risk-adjusted
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FIGURE 3. Association between surgical volume and risk-adjusted mortality by Aristotle difficulty (A, low difficulty, 3 [P ¼ .059, test of no volume-
mortality association]; B, high difficulty,>3 [P ¼ .007, test of no volume-mortality association]).The results of this study complement those of the largest
and most recent previous study of the volume–mortality
relationship in pediatric cardiac surgery.9 Although the 2
investigations were done with different types of data, both
found that larger programs performed better than smaller
programs. The previous study used the Nationwide Inpatient
Sample, which is an involuntary administrative database,
which is a stratified cross-sectional sample that includes
approximately 20% of all community (nonfederal) hospital
discharges in the United States selected from a sampling
frame that comprises approximately 90% of all hospital
discharges in the United States. The STS Congenital Heart
Surgery Database, as used in the present study, is a voluntary
clinical database. As such, the participants are more likely
to be higher-volume programs specializing in congenital
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FIGURE 4. Association between hospital volume and risk-adjusted mor-
tality for Norwood operations (P< .001, test of no volume-mortality asso-
ciation).1138 The Journal of Thoracic and Cardiovascular Scardiac surgery. Consequently, the volume categorizations
differed between the 2 studies. Despite this population
difference and the greater ability for risk adjustment with
clinical data, the findings of the 2 studies were similar.
The limitations of this study are a result of the choice of
the data source. The STS Congenital Heart Surgery Data-
base was designed primarily for quality improvement. The
database contains a self-selected group of centers that volun-
tarily chose to submit data. The data were collected by indi-
viduals at the institutions, many of whom have a stake in the
outcomes of the program. Although some have questioned
the validity of such data because of this involvement, the
contributions of clinical personnel to the data collection
process and the design of the database specifically for con-
genital cardiac surgery might result in higher-quality data
and superior risk adjustment. Unfortunately, at the time of
the data collection for this study, there was no data audit
process to ensure accuracy. The consistency of the aggregate
morality rates and the volume–mortality relationships with
previous reports supports the quality of the database.
Because we did not have information on preoperative
decision making, we were not able to assess the appropriate-
ness of the operations performed. For example, for a certain
diagnosis, a patient might receive an operation with a lower
in-hospital mortality rate but lower long-term survival rather
than a more appropriate operation with a higher up-front mor-
tality and better long-term survival. In addition, the choice of
the low-mortality operation might necessitate a second oper-
ation, resulting in a higher combined mortality rate. The lack
of long-term follow-up limited our ability to compare the
‘‘true’’ outcomes important to congenital heart surgery, in-
cluding not only mortality but also morbidity, functional sta-
tus, and neurologic status. Because the overall mortality rate
for our cohort was 3.7%, these outcomes, rather than in-hos-
pital mortality, are of importance to more than 96% of oururgery c May 2009
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Notwithstanding these limitations, our study was conducted
by using a national multicenter database with adequate power
to generate current, stable mortality rates.
CONCLUSION
We found overall unadjusted volume to be a poor discrim-
inator of mortality. However, after adjustment for patient
risk factors and surgical case mix, larger programs achieved
superior results for more complex operations. Many factors
contribute to the mortality risk of a patient undergoing pedi-
atric cardiac surgery. The relationship between volume and
mortality is complex, making volume a difficult choice as
a quality measure for pediatric cardiac surgery. Rather
than accepting an imperfect proxy, the process measures
and system characteristics for which volume is a surrogate
need to be identified. The widespread implementation of
these factors is likely to lead to substantial improvement in
the outcomes of our operations.
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Discussion
Dr J. William Gaynor (Philadelphia, Pa). I would like to con-
gratulate Dr Welke and his coinvestigators for a very important and
interesting study. They have used data from the STS congenital
database to investigate the relationship between center-based surgi-The Journal of Thoracic and Cacal volume and outcome as assessed based on hospital mortality.
This is an important and controversial topic because center volume
has been used as a quality measure.
Dr Welke and colleagues’ study shows that volume alone is
a poor predictor of outcome. However, after adjustment for patient
factors and case complexity, they did identify a complex relation-
ship between surgical volume and outcomes.
There is no relationship between volume and outcome for low-
complexity cases. However, for complex cases, particularly the
Norwood procedure, there was a significant relationship between
increasing surgical volume, particularly in very large centers of
greater than 350 patients a year, and improved outcomes.
This study complements and supports a previous study by Dr
Welke and his colleagues, which was presented at the STS meeting
earlier this year. In that study they used an administrative data set
and showed that surgeons in centers with a large annual case
volume performed more complex cases with better results than
those in smaller centers.
Use of case volume as a quality metric is obviously controver-
sial. Previous studies with administrative databases have been crit-
icized because of the lack of data quality and the lack of adequate
risk stratification.
The current study Dr Welke and his colleagues used the best avail-
able clinical database and the best available risk stratification to iden-
tify this relationship between volumes and clinical outcomes.
The goal of the STS database is quality improvement. We have
now identified a relationship that some centers might not want to
see; that is, there appears to be a relationship, at least for complex
cases, between increasing case volume and outcomes. And we have
done it using the best available tools.
Now, how can we use this information—you touched on this at
the end—for quality improvement? One idea that some payers and
other groups might suggest is to simply transfer complex cases
from low–volume centers to higher-volume centers. More impor-
tantly, we should try to improve quality and improve our outcomes.
As you suggested, volume is probably a surrogate for some other
factor: surgical experience, available facilities, number of surgeons,
or the health care team.
The question I would like to ask is this: How can we use these
data to try to identify those factors that we are measuring with vol-
ume? Volume is clearly not the determinant but rather is a surro-
gate for some other outcome measure. How can we identify those
factors that account for the improved outcomes in the larger
centers and then apply them to other centers to improve overall
quality?
Dr Welke. Thank you, Dr Gaynor, for your comments and
question.
Volume is not a measure of quality but is, as you stated, an easily
obtained structural attribute that is associated with quality. It is
a surrogate for process measures and structural characteristics of
systems that lead to better outcomes but are not currently captured
in available databases. Volume is associated with quality because,
on average, higher-volume programs are more likely to have these
structural characteristics and engage in these processes. These
factors might be associated with experience and systems of care.
You mentioned some likely candidates. To those I would add
preoperative decision making and care, intraoperative decision
making and care, postoperative in-hospital and postdischarge
care, multidisciplinary discussions, and team strength andrdiovascular Surgery c Volume 137, Number 5 1139
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ship, skilled cardiologists, pediatric perfusionists, and pediatric an-
esthesiologists. There are others. I am sure that team experience and
interaction are crucial.
Although studying these factors is more time consuming and
costly than tracking mortality, defining and implementing such mea-
sures are likely to result in better outcomes. How can we do that?
One model that has been very successful in adult cardiac surgery
is the regional quality improvement organization, the Northern
New England Cardiovascular Disease Study Group. In part because
of the geographic dispersion of the programs in our specialty, per-
haps a national or international organization such as this one, the
STS, or perhaps, most appropriately, the Congenital Heart Sur-
geons Society, would be best suited to expand on the Northern
New England Cardiovascular Disease Study Group concept in
our field. It could be a wonderful contribution and might be the
only way to tease out the structural characteristics and process mea-
sures that are central to high-quality care.
Mortality is a difficult outcome to use for tracking quality, in part
because we are good enough at what we do that it occurs relatively
infrequently. We need to broaden our focus to include other out-
comes, both because they occur more frequently and also because
they are important to patients: morbidity, functional status, neuro-
logic status, and long–term mortality.
Dr JanM.Quaegebeur (New York, NY). Dr Welke, you just put
water in my well. Thank you.
I have been involved with the database of New York State, and I
want to correct a misconception. The New York State database is
not an administrative database because for every patient who un-
dergoes an operation, at the time of the operation, forms have to
be filled in and risk factors have to be identified, which are then
controlled by the state by means of peer review. Therefore these
publications by Hannan that you mentioned already preceded
your conclusions, and we totally agree.
I also agree with your last sentence, stating that death, of course,
is the ultimate outcome. Therefore the more complex the proce-
dure, the more evident that the relationship exists. If you want to
become more sensitive about what really is the quality of care of
patients in small and larger units, we have to look at other outcomes
than that alone in terms of morbidity, as you mentioned. I think that
is very important, but it is not going to be easy to organize that.
Dr Welke. Thank you for your comments, and thank you for
your comment about the New York data. Ed Hannan has been1140 The Journal of Thoracic and Cardiovascular Suone of the pioneers in looking at this subject, as have all of you
who have supported him in New York. The New York clinical car-
diac surgery database is the only other clinical database that has
been used to examine the volume–mortality relationship in pediat-
ric cardiac surgery. The other studies have been done with primarily
California administrative data. One study included California and
Massachusetts administrative data, and our previous study used
data from the Nationwide Inpatient Sample. But as you mentioned,
Ed Hannan is a real pioneer and has done great work in this area.
Dr Carlos J. Troconis (Venezuela and Dominican Republic). In
the Dominican Republic we have had the experience of and devel-
oped a brand new program. In 2006, we did a study in which we
evaluated 111 cases performed by our locally trained group versus
169 patients operated on by American teams visiting us. The pa-
tients’ risk stratifications were the same for both groups:
RACHS–1 score up to 3 and Aristotle score of less than 3. In
reviewing our results in terms of mortality, we found it within
the range applied for most American centers but less than the vis-
itor’s teams. In summary, the mortality and morbidity were higher
than our result for the same adjusted risk categorization of patients.
My concerns are—and that might be your conclusion—that the
different environmental conditions might influence the perfor-
mance of the visiting teams versus the creativity of ‘‘tropicaliza-
tion’’ of the local teams habituated to such situations. I think that
more collaborative efforts should be done between both worlds
to enhance these results. Do you have any comments about this?
Dr Welke. First, I congratulate you on your results. You have
brought up an important point. Cardiac surgery is a team sport,
and the context matters. If you take one element of a complex
team, in this case a group of surgeons from the United States, per-
haps even with supporting staff, out of the environment to which
they are accustomed and move them to a new environment, in
this case your hospital, they might not be able to function optimally.
Your environment might be more or less sophisticated than what
they are used to at home, but it does not matter. It is just different,
and they are not used to it. You and your team are used to the en-
vironment, and therefore it makes sense that you get better results.
The answer to improving their results is communication and
collaboration. Work with them to adjust them to your environment.
Combine their expertise with your experience and expertise. Again,
you have brought up an excellent point. What you describe is a case
study of what we are discussing: how the team and the whole
system matter.rgery c May 2009
